Johnson & Johnson KNEES — Percent Change (as a percent) increased by 880.0% to 23.4% in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 78.6%, from 13.1% to 23.4%. This is a positive signal — higher values indicate stronger performance for this metric.
Positive growth suggests successful product adoption or market expansion, whereas negative growth indicates declining demand or loss of market share to competitors.
This metric measures the period-over-period percentage growth or decline in net sales for the knee replacement product l...
Comparable to organic growth rates for orthopedic segments reported by major medical device manufacturers.
jnj_segment_knees_percent_change_as_a_percent| Q2 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -19.1% | 21.1% | 32.6% | 19.4% | -1.8% | -2.6% | 24.5% | 23.6% | 28.2% | 27.5% | 13.1% | -8.3% | -3% | 23.4% |
| QoQ Change | — | +210.5% | +54.5% | -40.5% | -109.3% | -44.4% | >999% | -3.7% | +19.5% | -2.5% | -52.4% | -163.4% | +63.9% | +880.0% |
| YoY Change | — | — | — | +201.6% | — | -112.3% | +26.3% | >999% | — | +12.2% | -44.5% | -129.4% | -110.9% | +78.6% |
We use cookies for analytics. See our Privacy and Cookie Policy.